Johannesburg, South Africa, April 30th, 2020 – Republic of South Africa Medical Marijuana Dispensaries Pty Ltd. (RSAMMD) is pleased to announce it has executed a letter of intent with USA-based Protext Pharma, Inc (OTC PINK: TXTM)., a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated from highly-bioavailable plant extracts. Under the terms of the agreement, the companies will form a joint venture partnership to (i) test Protext’s proprietary...